The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Expression III: What do primary and recurrent ovarian cancer (OC) patients expect from their doctors and therapy management? Results of a survey in eight European countries with 1,743 patients (NOGGO/ENGOT-OV9 study).
Gülten Oskay-Özcelik
No relevant relationships to disclose
Maren Keller
No relevant relationships to disclose
Sandro Pignata
No relevant relationships to disclose
Domenica Lorusso
No relevant relationships to disclose
Florence Joly
No relevant relationships to disclose
Dominique Berton-Rigaud
No relevant relationships to disclose
Ignace Vergote
No relevant relationships to disclose
Joke De Roover
No relevant relationships to disclose
Michal Maciejewski
No relevant relationships to disclose
Marcin Jedryka
No relevant relationships to disclose
Antonio Casado Herraez
No relevant relationships to disclose
C. Mendiola
No relevant relationships to disclose
Antonio Gonzalez-Martin
No relevant relationships to disclose
Patrick Achimas
No relevant relationships to disclose
Daniel Uwe Reimer
No relevant relationships to disclose
Alain G Zeimet
No relevant relationships to disclose
Hans-Joachim Hindenburg
No relevant relationships to disclose
Rolf Richter
No relevant relationships to disclose
Jalid Sehouli
No relevant relationships to disclose